Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds

US12358952B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12358952-B2
Application numberUS-202218272674-A
CountryUS
Kind codeB2
Filing dateJan 19, 2022
Priority dateJan 19, 2021
Publication dateJul 15, 2025
Grant dateJul 15, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention described herein includes a novel platform for the development of novel shapeshifting drug-like compounds that overcome physical mass limitations as they possess the ability to interconvert internally and spontaneously, i.e., shapeshift, between multiple chemical structures with varying pharmacophore properties. In one preferred embodiment, the invention include systems, methods, and compositions for the synthesis of novel bullvalene amino acid (Bvas) compounds that may further be incorporated into Shape Shifting Cyclic Peptides (SSCP) with varying pharmacophore properties and their use as novel therapeutic compounds.

First claim

Opening claim text (preview).

What is claimed is: 1. A di-substituted bullvalene amino acid (Bva) composition according to Formula (I-A): wherein R is H, a protecting group, Boc, or Fmoc. 2. A tri-substituted bullvalene amino acid (Bva) composition according to Formula (I-B): wherein R is H, a protecting group, Boc, or Fmoc; and wherein  comprises a canonical and/or non-canonical side-chain optionally selected from the group consisting of: 3. The composition of claim 1 , wherein the composition comprises an Fmoc-Bva and is further incorporated into a Fmoc-solid phase peptide synthesis (SPPS) system forming a linear peptide coupled with said Fmoc-Bva which can be cyclized forming a Shape Shifting Cyclic Peptide (SSCP). 4. The composition of claim 2 , wherein the composition comprises an Fmoc-Bva and is further incorporated into a Fmoc-solid phase peptide synthesis (SPPS) system forming a linear peptide coupled with said Fmoc-Bva which can be cyclized forming a Shape Shifting Cyclic Peptide (SSCP).

Assignees

Inventors

Classifications

  • on carriers {(C07K1/003, C07K1/006 take precedence)} · CPC title

  • of peptides containing derivatised side chain amino acids · CPC title

  • Design of libraries · CPC title

  • C07K7/56Primary

    the cyclisation not occurring through 2,4-diamino-butanoic acid · CPC title

  • by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12358952B2 cover?
The invention described herein includes a novel platform for the development of novel shapeshifting drug-like compounds that overcome physical mass limitations as they possess the ability to interconvert internally and spontaneously, i.e., shapeshift, between multiple chemical structures with varying pharmacophore properties. In one preferred embodiment, the invention include systems, methods, …
Who is the assignee on this patent?
Univ Colorado Regents
What technology area does this patent fall under?
Primary CPC classification C07K7/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).